Minerva Neurosciences (NERV) Current Leases (2019 - 2021)

Minerva Neurosciences posted quarterly Current Leases of $16288.0 for Q2 2021, down 91.19% year-on-year from $184777.0 in Q2 2020, and down 74.69% on a QoQ basis from $64350.0 in Q1 2021.

Minerva Neurosciences (NERV) has 3 years of Current Leases data on file, last reported at $16288.0 in Q2 2021.

  • For the quarter ending Q2 2021, Current Leases fell 91.19% year-over-year to $16288.0; the trailing twelve-month figure through Jun 2021 stood at $16288.0 (down 91.19% YoY), and the FY2020 full-year result was $111229.0, down 35.67% from the prior year.
  • Current Leases for Q2 2021 stood at $16288.0, down from $64350.0 in the prior quarter.
  • Across five years, Current Leases topped out at $184777.0 in Q2 2020 and bottomed at $16288.0 in Q2 2021.
  • The 3-year median for Current Leases is $159279.0 (2019), against an average of $137020.8.
  • The widest annual swing landed in 2020, when Current Leases gained 14.48%; it then tumbled 91.19% in 2021.
  • A 3-year view of Current Leases shows it stood at $172901.0 in 2019, then sank by 35.67% to $111229.0 in 2020, then tumbled by 85.36% to $16288.0 in 2021.
  • The last three Current Leases figures came in at $16288.0 (Q2 2021), $64350.0 (Q1 2021), and $111229.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 16,288.00
Mar 31, 2021 64,350.00
Dec 31, 2020 111,229.00
Sep 30, 2020 156,956.00
Jun 30, 2020 184,777.00
Mar 31, 2020 178,765.00
Dec 31, 2019 172,901.00
Sep 30, 2019 167,181.00
Jun 30, 2019 161,602.00
Mar 31, 2019 156,159.00